| Product Code: ETC13365597 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Pharmacogenomics Technology Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Pharmacogenomics Technology Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Pharmacogenomics Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Pharmacogenomics Technology Market - Industry Life Cycle |
3.4 Africa Pharmacogenomics Technology Market - Porter's Five Forces |
3.5 Africa Pharmacogenomics Technology Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Pharmacogenomics Technology Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 Africa Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Africa Pharmacogenomics Technology Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.9 Africa Pharmacogenomics Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Africa Pharmacogenomics Technology Market Revenues & Volume Share, By Market Driver, 2021 & 2031F |
4 Africa Pharmacogenomics Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Pharmacogenomics Technology Market Trends |
6 Africa Pharmacogenomics Technology Market, 2021 - 2031 |
6.1 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Genotyping, 2021 - 2031 |
6.1.3 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031 |
6.1.4 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Gene Expression Profiling, 2021 - 2031 |
6.1.5 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Bioinformatics Solutions, 2020 - 2028 |
6.1.6 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Companion Diagnostics, 2020 - 2028 |
6.2 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Personalized Medicine, 2021 - 2031 |
6.2.3 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Drug Response Analysis, 2021 - 2031 |
6.2.4 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Oncology Treatment, 2021 - 2031 |
6.2.5 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Adverse Drug Reactions, 2021 - 2031 |
6.2.6 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Clinical Trials, 2020 - 2028 |
6.3 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Pharmacogenomics Technology Market, Revenues & Volume, By PCR-Based, 2021 - 2031 |
6.3.3 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Microarray, 2021 - 2031 |
6.3.4 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031 |
6.3.5 Africa Pharmacogenomics Technology Market, Revenues & Volume, By AI-Based Analytics, 2021 - 2031 |
6.3.6 Africa Pharmacogenomics Technology Market, Revenues & Volume, By DNA Microarray, 2021 - 2031 |
6.4 Africa Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Pharma Companies, 2021 - 2031 |
6.4.3 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.4 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Research Labs, 2020 - 2028 |
6.4.5 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Academic Institutions, 2020 - 2028 |
6.4.6 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Diagnostic Centers, 2020 - 2028 |
6.5 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Advancements in Precision Medicine, 2020 - 2028 |
6.5.3 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Increase in Genetic Testing, 2020 - 2028 |
6.5.4 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Growing Interest in Targeted Therapy, 2020 - 2028 |
6.5.5 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Expansion in Pharmacovigilance, 2020 - 2028 |
6.5.6 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Demand for Tailored Therapeutics, 2020 - 2028 |
7 Africa Pharmacogenomics Technology Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.1 South Africa Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.2 Egypt Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.3 Nigeria Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.2.4 Rest of Africa Pharmacogenomics Technology Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3 Africa Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 South Africa Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Egypt Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Nigeria Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.4 Rest of Africa Pharmacogenomics Technology Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.1 South Africa Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.2 Egypt Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.3 Nigeria Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.4.4 Rest of Africa Pharmacogenomics Technology Market, Revenues & Volume, By Testing Method, 2021 - 2031 |
7.5 Africa Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 South Africa Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Egypt Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Nigeria Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.4 Rest of Africa Pharmacogenomics Technology Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 Africa Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.1 South Africa Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.2 Egypt Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.3 Nigeria Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
7.6.4 Rest of Africa Pharmacogenomics Technology Market, Revenues & Volume, By Market Driver, 2021 - 2031 |
8 Africa Pharmacogenomics Technology Market Key Performance Indicators |
9 Africa Pharmacogenomics Technology Market - Export/Import By Countries Assessment |
10 Africa Pharmacogenomics Technology Market - Opportunity Assessment |
10.1 Africa Pharmacogenomics Technology Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Pharmacogenomics Technology Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
10.3 Africa Pharmacogenomics Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 Africa Pharmacogenomics Technology Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
10.5 Africa Pharmacogenomics Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 Africa Pharmacogenomics Technology Market Opportunity Assessment, By Market Driver, 2021 & 2031F |
11 Africa Pharmacogenomics Technology Market - Competitive Landscape |
11.1 Africa Pharmacogenomics Technology Market Revenue Share, By Companies, 2022 |
11.2 Africa Pharmacogenomics Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here